Compositions and methods for immune cell modulation in adoptive immunotherapies
US11413309B2 · kind B2 · utility
4Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2017 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Dec 11, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies with improved efficacy are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.